FDA inspection
Gregory Pharmaceutical Holdings Inc.: FDA inspection ending Apr 12, 2019
FDA inspection 1086261 · Voluntary Action Indicated (VAI) · Bristol, TN
Key facts
| Inspection ID | 1086261 |
|---|---|
| Firm | Gregory Pharmaceutical Holdings Inc. |
| FEI number | 1000208638 |
| Address | 501 5th St |
| City | Bristol |
| State | TN |
| ZIP | 37620 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Apr 12, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data